There are 2867 resources available
CN27 - Exploring the quality of dying and death of patients with cancer undergoing palliative care (PC)
Presenter: STYLIANOS KATSARAGAKIS
Session: Palliative and end-of-life care
Resources:
Abstract
LBA23 - Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
Presenter: Julien Taieb
Session: Proffered Paper session 1: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Susan Chang
Session: Lessons learned and new horizons for treatment of primary brain tumours
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Chia-Chi Lin
Session: What’s old is new again
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Carsten Denkert
Session: New classification and staging of breast cancer
Resources:
Slides
Webcast
Invited Discussant 1359MO and 1361MO
Presenter: Boris Hadaschik
Session: Mini Oral session: GU tumours, prostate
Resources:
Slides
Webcast
Invited Discussant LBA57 and LBA58
Presenter: Tony S.K. Mok
Session: Mini Oral session: NSCLC, metastatic
Resources:
Slides
Webcast
Cancer of Unknown Primary site (CUP): Discussion / Q&A
Presenter: All Speakers
Session: ESMO Clinical Practice Guidelines session 1
Resources:
Webcast
CN23 - The end of life – a topic we avoid: The Croatian National Cancer Patient Experience Survey
Presenter: Andreja Sajnic
Session: Palliative and end-of-life care
Resources:
Abstract
LBA59 - Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)
Presenter: Melissa Johnson
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast